Zachary J.
Harmon
(Zack)

Represented a major oilfield services company in a multinational FCPA internal investigation in Africa and the Middle East, and in response to parallel investigations by the DOJ and SEC.

Represented a Singapore-based energy company in a high-profile FCPA/anti-corruption investigation by DOJ and the Indonesian KPK.

Representing numerous international corporations—including several Fortune 50 companies—in matters involving the Foreign Corrupt Practices Act, including international investigations (in Angola, Azerbajan, Bangladesh, Brazil, Brunei, Bulgaria, Canada, China, Czech Republic, the Dominican Republic, Egypt, Germany, Greece, India, Indonesia, Italy, Kazakhstan, Malaysia, Mexico, Nigeria, Poland, Russia, Saudia Arabia, Singapore, Switzerland, Turkey, the United Arab Emirates, and the United Kingdom), DOJ and SEC disclosures, and development of FCPA compliance programs, including:

Conducting multinational FCPA investigation (in Asia, India, Bangladesh and Latin America) for major freight forwarding company and assisting company with overhaul of compliance programs as well as self-disclosure to FCPA authorities—no action was taken by authorities;

Conducting multinational FCPA investigation (in five European countries) for one of the largest global medical device companies and representing company in discussions with FCPA authorities – received declinations from both the SEC and DOJ;

Conducting multinational FCPA investigation (in Brunei, Malaysia and India) for major oil field services company and advising company in decisions concerning self-disclosure;

Serving as primary outside FCPA counsel for several multinational companies, and assisting in all aspects of design implementation, and operation of companies’ FCPA compliance programs; and

Advising companies in FCPA due diligence related to significant mergers, acquisitions and divestitures.

Representing several senior partners of a Big Four accounting firm in a high-profile investigation by the U.S. Department of Justice Fraud Section and the SEC;

Defending a large U.S. corporation in a complex federal and international criminal tax investigation prosecuted by the Tax Division of the U.S. Department of Justice and the U.S. Attorney’s Office in Atlanta;

Representing a Native American tribe in investigations and proceedings by the U.S. Department of Justice and the U.S. Senate concerning the activities of Jack Abramoff;

Defending GlaxoSmithKline in a consumer fraud lawsuit brought by the New York Attorney General’s Office;

Representing an individual defendant in the then-largest international antitrust conspiracy investigation and litigation;

Representing a prominent Middle Eastern bank in an investigation by the National Security Division of the U.S. Department of Justice;

Representing an Egyptian national in a fraud investigation by the U.S. Attorney’s Office for the Southern District of New York;

Representing the managing partner of an accounting firm in a criminal tax investigation;

Defending the president of a large labor union in an investigation by the U.S. Department of Labor;

Representing drug and medical device companies in criminal and civil litigation involving the U.S. Department of Justice and various U.S. Attorney’s Offices regarding “off-label” promotion and other development, sales and marketing conduct;

Conducting a review of the FBI’s Office of Professional Responsibility;

Representing pharmaceutical supply companies in a civil action against the U.S. Drug Enforcement Administration regarding the seizure of drug product;

Representing a prominent government defense contractor in a Congressional investigation; and

Routinely serving as a panelist or as featured faculty at conferences and seminars throughout the world.